Talk about pressure :) I would guess about +$2 max is all.
I don't think the market is paying much of any attention to it as a 4th to market oral ED drug. But I would think in the long run they may be underestimating it. $150M+ peak sales wouldn't surprise me. Plus it could be synergistic, obesity+ED in men is common :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.